Morgan Stanley’s CYTEC INDS INC CYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-2,185,719
Closed -$161M 7020
2015
Q3
$161M Buy
2,185,719
+2,042,757
+1,429% +$142M 0.06% 337
2015
Q2
$8.65M Sell
142,962
-73,721
-34% -$4.29M ﹤0.01% 2243
2015
Q1
$11.7M Sell
216,683
-332,035
-61% -$16.6M ﹤0.01% 1908
2014
Q4
$25.3M Buy
548,718
+92,776
+20% +$4.32M 0.01% 1281
2014
Q3
$21.6M Buy
455,942
+135,356
+42% +$6.94M 0.01% 1385
2014
Q2
$16.9M Sell
320,586
-76,962
-19% -$3.8M 0.01% 1565
2014
Q1
$19.4M Buy
397,548
+139,444
+54% +$6.47M 0.01% 1401
2013
Q4
$12M Sell
258,104
-105,322
-29% -$4.57M 0.01% 1789
2013
Q3
$14.8M Buy
363,426
+213,036
+142% +$8.27M 0.01% 1460
2013
Q2
$5.51M Buy
+150,390
New +$5.5M ﹤0.01% 2234

Morgan Stanley's CYT Position: Q4 2015 in Review

Morgan Stanley sold out of CYTEC INDS INC (CYT) in Q4 2015, closing a stake of 2,185,719 shares — an estimated $161M sold.

Morgan Stanley first reported a position in CYT in Q2 2013 and held it in 10 quarters. The position peaked at $161M in Q3 2015. 0 funds tracked by Wall St. Rank hold CYT as of Q4 2015.

  • Morgan Stanley reported no remaining CYTEC INDS INC position as of Q4 2015 after selling out during the quarter.
  • Morgan Stanley sold 2,185,719 CYTEC INDS INC shares in Q4 2015, an estimated $161M.
  • Morgan Stanley first reported a position in CYTEC INDS INC in Q2 2013 and held it in 10 quarters.
  • Morgan Stanley's CYTEC INDS INC position peaked at $161M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held CYTEC INDS INC as of Q4 2015.

Based on Morgan Stanley's 13F filing for Q4 2015, filed 9 Feb 2016.